Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors (Q36187739)

12 August 2017

Stage II endometrial carcinoma: limiting post-operative radiotherapy to the vaginal vault in node-negative tumors (English)

1 reference

12 August 2017

endometrial carcinoma

1 reference

Paula V C Rittenberg

1

1 reference

12 August 2017

Robert J Lotocki

series ordinal

2

1 reference

12 August 2017

Mark S Heywood

series ordinal

3

1 reference

12 August 2017

Garry V Krepart

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

12 August 2017

1 reference

12 August 2017

98

1 reference

12 August 2017

3

1 reference

12 August 2017

434-438

1 reference

Stage II endometrial carcinoma: 10-year follow-up of combined radiation and surgical treatment

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

An audit of outcome of adjuvant post-operative radiotherapy for 52 women with stage II carcinoma of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

Post-operative high dose rate brachytherapy in patients with low to intermediate risk endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

Surgical staging and high dose rate brachytherapy for endometrial cancer: limiting external radiotherapy to node-positive tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

Postoperative vaginal vault brachytherapy for node-negative Stage II (occult) endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

The value of pelvic and para-aortic lymphadenectomy in endometrial cancer to avoid unnecessary radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

Adjuvant radiotherapy following properly staged endometrial cancer: what role?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.04.030

10.1016/J.YGYNO.2005.04.030

7 January 2021

Identifiers

DOI

1 reference

12 August 2017

1 reference